跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag - TGA Drug Approval Details
Approvals
/
TGA
/
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag
Approved
STANDARD
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f8060c6e8b63db40
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
f8060c6e8b63db40
Product Name
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag
Artg Id
310404
Artg Name
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2019-12-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9e168c2090b24268e6b3db32a664102a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c66279ac060761721e82b083ff94e66b.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f8060c6e8b63db40
Type
Standard
Back to TGA Approvals